PHASE-I STUDY OF THE BIODISTRIBUTION, PHARMACOKINETICS AND IMMUNOGENICITY OF IN-111-HCTMO1 (CDP671)+ - PREDOSING WITH UNLABELED HCTMO1 IN PATIENTS (PTS) WITH LUNG-CANCER/

Citation
M. Verrill et al., PHASE-I STUDY OF THE BIODISTRIBUTION, PHARMACOKINETICS AND IMMUNOGENICITY OF IN-111-HCTMO1 (CDP671)+ - PREDOSING WITH UNLABELED HCTMO1 IN PATIENTS (PTS) WITH LUNG-CANCER/, European journal of cancer, 33, 1997, pp. 1114-1114
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
1114 - 1114
Database
ISI
SICI code
0959-8049(1997)33:<1114:PSOTBP>2.0.ZU;2-G